Recruiting Familial Hypercholesterolemia Studies in Philadelphia
About Familial Hypercholesterolemia Clinical Trials in Philadelphia
Familial hypercholesterolemia is a genetic condition causing very high LDL cholesterol levels from birth, dramatically increasing the risk of early heart disease. It affects about 1 in 250 people. Treatment includes high-intensity statins, PCSK9 inhibitors, and lifestyle modifications.
There are currently 2 familial hypercholesterolemia clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 1,085 participants. Research is being sponsored by University of Pennsylvania, Verve Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Familial Hypercholesterolemia Clinical Trials in Philadelphia — FAQ
Are there familial hypercholesterolemia clinical trials in Philadelphia?
Yes, there are 2 familial hypercholesterolemia clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What familial hypercholesterolemia treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for familial hypercholesterolemia.
Data updated October 16, 2026 from ClinicalTrials.gov